Atorvastatin administered before myocardial infarction in rats improves contractility irrespective of metabolic changes

Clinical and Experimental Pharmacology and Physiology

Volumn 41, Issue 12, 2014, Pages 986-994

  Lehnen, Tatiana Ederich ^a,b,c   Lehnen, Alexandre Machado ^a,b,c   Tavares, Angela Maria Vicente ^a   Belló Klein, Adriane ^a   Markoski, Melissa Medeiros ^c   Machado, Ubiratan Fabres ^d   Schaan, Beatriz ^a,b,c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Atorvastatin; Glucose transporter 4; Myocardial infarction

Indexed keywords

ATORVASTATIN; GLUCOSE TRANSPORTER 4; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG EFFECT; ECHOCARDIOGRAPHY; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; TIME TO TREATMENT;

EID: 84912569996     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12313     Document Type: Article

References (48)

1. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Eur. Heart J. 2007; 28: 2525-38.
2. Chen Y, Zhang Q, Liao YH et al. Effect of tumor necrosis factor-alpha on neutralization of ventricular fibrillation in rats with acute myocardial infarction. Mediators Inflamm. 2011; 2011: 1-8.
3. Tavares AM, da Rosa Araujo AS, Baldo G et al. Bone marrow derived cells decrease inflammation but not oxidative stress in an experimental model of acute myocardial infarction. Life Sci. 2010; 87: 699-706.
4. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc. Res. 2002; 53: 31-47.
5. Shibata M, Endo S, Inada K et al. Elevated plasma levels of interleukin-1 receptor antagonist and interleukin-10 in patients with acute myocardial infarction. J. Interferon Cytokine Res. 1997; 17: 145-50.
6. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-7.
7. Furuya DT, Poletto AC, Favaro RR, Martins JO, Zorn TM, Machado UF. Anti-inflammatory effect of atorvastatin ameliorates insulin resistance in monosodium glutamate-treated obese mice. Metabolism 2009; 59: 395-9.
8. Leguisamo NM, Lehnen AM, Machado UF et al. GLUT4 content decreases along with insulin resistance and high levels of inflammatory markers in rats with metabolic syndrome. Cardiovasc. Diabetol. 2012; 11: 1-10.
9. Furuya DT, Neri EA, Poletto AC et al. Identification of nuclear factor-kappaB sites in the Slc2a4 gene promoter. Mol. Cell. Endocrinol. 2013; 370: 87-95.
10. Taegtmeyer H, Hems R, Krebs HA. Utilization of energy-providing substrates in the isolated working rat heart. Biochem. J. 1980; 186: 701-11.
11. Goodwin GW, Taylor CS, Taegtmeyer H. Regulation of energy metabolism of the heart during acute increase in heart work. J. Biol. Chem. 1998; 273: 29 530-9.
12. Taegtmeyer H, Goodwin GW, Doenst T, Frazier OH. Substrate metabolism as a determinant for postischemic functional recovery of the heart. Am. J. Cardiol. 1997; 80: 3A-10A.
13. Tian R, Abel ED. Responses of GLUT4-deficient hearts to ischemia underscore the importance of glycolysis. Circulation 2001; 103: 2961-6.
14. Semeniuk LM, Kryski AJ, Severson DL. Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice. Am. J. Physiol. Heart Circ. Physiol. 2002; 283: H976-82.
15. Zhang RY, Yu P, Wang F, Shen JX, Wang YM. Effects of Trimetazidine upon ventricular remodeling and GLUT4 in diabetic rats after myocardial infarction. Zhonghua Yi Xue Za Zhi 2009; 89: 1240-5.
16. Sheng X, Wei L, Murphy MJ, MacDonald TM. Statins and total (not LDL) cholesterol concentration and outcome of myocardial infarction: Results from a meta-analysis and an observational study. Eur. J. Clin. Pharmacol. 2009; 65: 1071-80.
17. Wang CY, Liu PY, Liao JK. Pleiotropic effects of statin therapy: Molecular mechanisms and clinical results. Trends Mol. Med. 2008; 14: 37-44.
18. Furuya DT, Poletto AC, Favaro RR, Martins JO, Zorn TM, Machado UF. Anti-inflammatory effect of atorvastatin ameliorates insulin resistance in monosodium glutamate-treated obese mice. Metabolism 2010; 59: 395-9.
19. Stumpf C, Petzi S, Seybold K et al. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction. Clin. Sci. (Lond) 2009; 116: 45-52.
20. Kleemann R, Verschuren L, de Rooij BJ et al. Evidence for anti-inflammatory activity of statins and PPARalpha activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro. Blood 2004; 103: 4188-94.
21. Wong V, Stavar L, Szeto L et al. Atorvastatin induces insulin sensitization in Zucker lean and fatty rats. Atherosclerosis 2006; 184: 348-55.
22. Lalli CA, Pauli JR, Prada PO et al. Statin modulates insulin signaling and insulin resistance in liver and muscle of rats fed a high-fat diet. Metabolism 2008; 57: 57-65.
23. NIH. Guide for the Care and Use of Laboratory Animals. Washingtion, DC: National Academy Press. 1996.
24. Garjani A, Andalib S, Biabani S, Soraya H, Doustar Y, Maleki-Dizaji N. Combined atorvastatin and coenzyme Q10 improve the left ventricular function in isoproterenol-induced heart failure in rat. Eur. J. Pharmacol. 2011; 666: 135-41.
25. Lazar HL, Bao Y, Zhang Y, Bernard SA. Pretreatment with statins enhances myocardial protection during coronary revascularization. J. Thorac. Cardiovasc. Surg. 2003; 125: 1037-42.
26. Arca M. Atorvastatin efficacy in the prevention of cardiovascular events in patients with diabetes mellitus and/or metabolic syndrome. Drugs 2007; 67 (Suppl. 1): 43-54.
27. Arca M, Gaspardone A. Atorvastatin efficacy in the primary and secondary prevention of cardiovascular events. Drugs 2007; 67 (Suppl. 1): 29-42.
28. de Macedo Braga LM, Lacchini S, Schaan BD et al. In situ delivery of bone marrow cells and mesenchymal stem cells improves cardiovascular function in hypertensive rats submitted to myocardial infarction. J. Biomed. Sci. 2008; 15: 365-74.
29. Pfeffer MA, Pfeffer JM, Fishbein MC et al. Myocardial infarct size and ventricular function in rats. Circ. Res. 1979; 44: 503-12.
30. Braga LM, Rosa K, Rodrigues B et al. Systemic delivery of adult stem cells improves cardiac function in spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 2008; 35: 113-9.
31. Cury AF, Bonilha A, Saraiva R et al. Myocardial performance index in female rats with myocardial infarction: Relationship with ventricular function parameters by Doppler echocardiography. J. Am. Soc. Echocardiogr. 2005; 18: 454-60.
32. Litwin SE, Katz SE, Weinberg EO, Lorell BH, Aurigemma GP, Douglas PS. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. Circulation 1995; 91: 2642-54.
33. Nozawa E, Kanashiro RM, Murad N et al. Performance of two-dimensional Doppler echocardiography for the assessment of infarct size and left ventricular function in rats. Braz. J. Med. Biol. Res. 2006; 39: 687-95.
34. Cheitlin MD, Armstrong WF, Aurigemma GP et al. ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J. Am. Soc. Echocardiogr. 2003; 16: 1091-110.
35. Peron A, Saraiva R, Antonio E, Tucci P. Mechanical function is normal in remanent myocardium during the healing period of myocardial infarction-despite congestive heart failure. Arq. Bras. Cardiol. 2006; 86: 105-12.
36. Mercier J, DiSessa T, Jarmakani J et al. Two-dimensional echocardiographic assessment of left ventricular volumes and ejection fraction in children. Circulation 1982; 65: 962-9.
37. Tavares A, Araújo A, Lesuy S et al. Early loss cardiac function in acute myocardial infarction is associated with redox imbalance. Exp. Clin. Cardiol. 2012 Winter; 17: 263-7.
38. Machado U, Shimizu I, Saito M. Reduced content and preserved translocation of glucose transporter (GLUT 4) in white adipose tissue of obese mice. Physiol. Behav. 1994; 55: 621-5.
39. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 72: 248-54.
40. Ferguson RE, Carroll HP, Harris A, Maher ER, Selby PJ, Banks RE. Housekeeping proteins: A preliminary study illustrating some limitations as useful references in protein expression studies. Proteomics 2005; 5: 566-71.
41. Ji G, Zhao X, Leng L, Liu P, Jiang Z. Comparison of dietary control and atorvastatin on high fat diet induced hepatic steatosis and hyperlipidemia in rats. Lipids Health Dis. 2011; 10: 23.
42. Cheng G, Xu G, Cai HW, Wang HH, Bao XF. Effect of atorvastatin on non-ischemic heart failure and matrix metalloproteinase-2 and 9 in rats. Acta Pharmacol. Sin. 2007; 28: 511-7.
43. Song XJ, Yang CY, Liu B et al. Atorvastatin inhibits myocardial cell apoptosis in a rat model with post-myocardial infarction heart failure by downregulating ER stress response. Int. J. Med. Sci. 2011; 8: 564-72.
44. Nishino Y, Miura T, Miki T et al. Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection. Cardiovasc. Res. 2004; 61: 610-9.
45. Lima GA, Anhe GF, Giannocco G, Nunes MT, Correa-Giannella ML, Machado UF. Contractile activity per se induces transcriptional activation of SLC2A4 gene in soleus muscle: Involvement of MEF2D, HIF-1a, and TRalpha transcriptional factors. Am. J. Physiol. Endocrinol. Metab. 2009; 296: E132-8.
46. Nakata M, Nagasaka S, Kusaka I, Matsuoka H, Ishibashi S, Yada T. Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): Implications in glycaemic control. Diabetologia 2006; 49: 1881-92.
47. Takaguri A, Satoh K, Itagaki M, Tokumitsu Y, Ichihara K. Effects of atorvastatin and pravastatin on signal transduction related to glucose uptake in 3T3L1 adipocytes. J. Pharmacol. Sci. 2008; 107: 80-9.
48. Sun YM, Tian Y, Li X et al. Effect of atorvastatin on expression of IL-10 and TNF-alpha mRNA in myocardial ischemia-reperfusion injury in rats. Biochem. Biophys. Res. Commun. 2009; 382: 336-40.